News & Insights

Editor’s Note: This is the second in a two-part blog series that takes us along with Rondo Therapeutics co-founder and...

Editor’s Note: This is the first in a multi-part blog series that takes us along with Rondo Therapeutics co-founder and...

Once again, Antibody Solutions was proud to participate as an event sponsor in the annual Antibody Engineering and...

Antibody Solutions will be attending PEGS 2023, to be held May 15-19 in Boston, MA.

PEGS: The Essential Protein...

Antibody Solutions will be attending AET 2022, to be held December 4-8 in San Diego, CA.

AET: The Antibody Engineering...

In 1902, the French filmmaker George Mèliés fascinated audiences with his film, Le Voyage dans la Lune (A Trip to the...

Antibody Solutions will be attending PEGS 2022, to be held May 2-6 in Boston, MA.

PEGS: The Essential Protein...

When the Omicron variant of SARS-CoV-2 was first identified, we applied our molecular modeling methods to assess how...

On November 24, 2021, South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World...

The Delta variant has quickly become the predominant strain of SARS-CoV-2. Based on molecular modeling studies,...

Candidate ID: How to go from hits to lead candidates

We tend to think of antibodies as being defined by their...

Like our research colleagues across the entire global scientific community, our team here at Antibody Solutions...

A strategic approach to peptide design yields success

When deciding which antigens to use for an antibody discovery...

If the last year has taught us anything, it’s that major biological threats can emerge seemingly out of nowhere,...

Here at Antibody Solutions, we believe that starting with the best possible input will yield the best possible output....